HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazumi Takehana Selected Research

Infections

4/2024Outbreak of Streptococcus pyogenes emm89 ST646 in a head and neck surgical oncology ward.
1/2022Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.
3/2021Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazumi Takehana Research Topics

Disease

3Infections
04/2024 - 03/2021
3Neoplasms (Cancer)
03/2021 - 04/2004
1Surgical Wound Infection
04/2024
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2024
1Bacteremia
01/2022
1Sepsis (Septicemia)
01/2020

Drug/Important Bio-Agent (IBA)

1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
01/2022
1Carbapenems (Carbapenem Antibiotics)IBA
01/2022
1Inosine Monophosphate (IMP)IBA
03/2021
1Polyvinyl Chloride (PVC)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
04/2004

Therapy/Procedure

1Tracheotomy
04/2024
1Tracheostomy
04/2024
1Catheters
01/2020